Skip to main content
. 2018 Sep 28;12:175. doi: 10.3389/fnbeh.2018.00175

Table 2.

Dysregulated lncRNAs in neurodegenerative diseases.

lncRNAs Direction of change Relative disease Biological function References
Sox2OT Up AD, PD Regulate cotranscribed Sox2 gene expression to down neurogenesis. Arisi et al., 2011; Shimozaki, 2014
BC200 up(Soma) down(Dentritic) AD, PD Modulate local proteins in postsynaptic dendritic micro-domains to maintenance of long-term synaptic plasticity. Lukiw et al., 1992; Mus et al., 2007; Vucićević et al., 2014; Luo and Chen, 2016
BACE1-AS up AD Increase BACE1 mRNA stability resulting in additional Aβ42 generation through a post-transcriptional feed-forward mechanism. Faghihi et al., 2008; Liu et al., 2014
NAT-Rad18 up AD Down the expression of DNA repair protein Rad18 resulting in the neuron being more sensitive to apoptosis. Parenti et al., 2007
NDM29 up AD Promotes Aβ secretion with increased Aβ42/ Aβ40 ratio, expression induced by inflammatory processes. Massone et al., 2012
51A up AD Promotes the alternative splicing of SORL1 and increases Aβ formation. Ciarlo et al., 2013; Tan et al., 2013; Luo and Chen, 2016
17A up AD Impair GABAB signaling pathway by decreasing GABAB R2 transcription. Massone et al., 2011
GDNFOS Dysregulated/differences in tissue expression patterns AD Modulate the expression of endogenous GDNF in human brain. Airavaara et al., 2011
naPINK1 up PD Stabilize the svPINK1, resulting in disturbed mitochondrial respiratory chain, and then increase the sensitivity to apoptosis. Chiba et al., 2009; Sai et al., 2012
PINK1-AS - PD Positively regulates the stability of svPINK1 transcript. Scheele et al., 2007
UCHL1-AS - PD Positively regulates UCHL1 mRNA translation. Carrieri et al., 2012, 2015
HAR1 down HD Necessary for retinal development, the function with HD not be mentioned. Johnson et al., 2010; Johnson, 2012
HTT-AS down HD HTTAS-v1 specifically reduces endogenous HTT transcript levels. Chung et al., 2011
MEG3 down HD Binds the PCR2 epigenetic silencing complex. Johnson, 2012

AD, Alzheimer's disease; PD, Parkinson's disease; HD, Huntington's disease; Sox2OT, Sox2 overlapping transcript; BACE1-AS, β-site amyloid precursor protein cleaving enzyme 1 antisense; GDNFOS, glial cell derived neurotrophic factor opposite strand; HAR1, human accelerated region 1; HTT-AS, Huntingtin antisense; PINK1-AS, PTEN induced putative kinase 1 antisense; UCHL1-AS, ubiquitin C-terminal hydrolase L1 antisense; MEG3, maternally expressed 3; NDM29, Neuroblastoma Differentiation Marker 29.